ICE Program Advisors and Staff

 

Advisors and Partners at Columbia University

This program would not have been possible without the support, advice and encouragement from senior members

of the Pathology Department at the Vagelos College of Physicians and Surgeons at Columbia University,

New York, NY, USA and the support of our Columbia partners.

Advisors:

Paulette Bernd, PhD 

Professor and Course Director for Clinical Anatomy, Department of Pathology and Cell Biology, 

Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA 

Kevin Roth, MD PhD 

Professor, and Chairman of the Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons,

Columbia University, New York, NY, USA 

Michael Shelanski, MD PhD

Professor, past Chairman of the Department of Pathology and Cell Biology and current Senior Vice Dean for Research

Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. 

Carol, Kunzel, PhD 

Director of Research at the College of Dental Medicine, 

Columbia University Irving Medical Center, New York, NY, USA.

 

Anna Getselman  

Associate Dean of Hammer Health Sciences Library at Columbia University 

Columbia University Irving Medical Center, New York, NY, USA.

Interschool Partners:

Columbia College: Ariella Lang, PhD

Columbia Graduate School of Arts and Sciences: Yinghui Mao, PhD

Columbia Mailman School of Public Health: Michael Joseph, PhD

 

External Advisory Board to the ICE Program

We are grateful for input, advice and support from our External Advisory Board.

Leo Buehler, MD

Professor of Surgery, University of Fribourg, Fribourg, Switzerland

Snehal Patel, MD, JD

Dr. Patel is the Chief Executive Officer & Co-Founder of MyDoc, a leading telemedicine

company active in seven countries across South and Southeast Asia, as well as the US. In

addition, Dr. Patel serves as the Managing Director of Saena Partners, an investment firm

that has led the initial funding of several innovative firms in Asia that range from pioneers in

ecologically friendly circular packaging technology to luxury distribution.

A Kauffman Fellow, Dr. Patel moved to Singapore from the US in 2008 to found and lead the

healthcare investment team at the Clermont Group, a multi-billion dollar investment fund.

Prior to practising law at Cravath, Swaine & Moore, LLP in New York, Dr. Patel received an

MD and a JD from Columbia University and served as a Clinical Fellow at the Harvard

Medical School.

Geoffroy Noel, PhD (see bio under partner faculty)

Professor of Anatomy, University of California San Diego, USA

Director, Division of Anatomical Sciences at McGill University, Montreal, QC, Canada (past position)

Chief, Division of Anatomy at the University of California San Diego, La Jolla, CA, USA (current position)

Takeshi Sakurai, PhD (see bio under partner faculty)

Professor of Anatomy, Kyoto University, Kyoto, Japan (past position)

Adjunct professor at Kyoto University Graduate School of Medicine, Japan; Nagoya University School of Medicine, Japan; 

and Juntendo University School of Medicine, Japan. Adjunct professor at Columbia University, USA.

Mark Hardy, MD

Professor of Surgery, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA

Mark A. Hardy is Auchincloss Professor of Surgery, Director Emeritus of the Transplant Centre, and Vice Chairman and Residency Program Director of the Department of Surgery at the Columbia University College of Physicians and Surgeonsand NewYork-Presbyterian Hospital in New York City.

Hardy is most recognized for co-founding the New York Organ Donor Network in 1978 (NYODN 2006). In addition to his work in transplantation, in the earlier part of his career he made several contributions to the development of prosthetic vascular grafts and the development and studies of biologic function of thymic hormones, both experimentally and clinically.

Hardy laid another cornerstone of organ transplant medicine by helping found the program for dialysis and kidney transplantation at NewYork-Presbyterian Hospital. He based the new program on the principle of combined clinical care between surgeons and nephrologists during a time when renal transplant programs were managed by one or the other discipline, never by both at once (CUMC Programs 2007). This cooperation between disciplines led to major contributions in immunogeneticsimmunosuppression, and treatment of autoimmune diseases and lymphoma (CUMC Programs 2007).

His most recent focus has been on cellular transplantation with emphasis on islet transplantation. Hardy is Principal Investigator of a multicenter clinical trial exploring a combination of two immunosuppressant drugs, sirolimus and tacrolimus (CUMC 2007 Kidney). He also currently a member of several multiinstitutional studies of immunosuppressive agents which are individually sponsored by NovartisAstellas and Bristol Myers.

 


Webmasters 

Monica Kieff (New York) - website first edition 2018

Contact: mrk2188@cumc.columbia.edu

Social Media Masters

Alexandra Matschiner (Halle) -Facebook 2017 and 2018

Benedicte Lauritzen (Copenhagen)- Facebook 2019

Rachel Utomo (Columbia) - Slack 2021

Other media

Monica Kieff (New York) - video and photos

Carol Liu (New York) - video 2018 edition

Katrina Tan (London) - video 2021 edition